ES2038689T3 - Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido. - Google Patents

Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido.

Info

Publication number
ES2038689T3
ES2038689T3 ES198787460013T ES87460013T ES2038689T3 ES 2038689 T3 ES2038689 T3 ES 2038689T3 ES 198787460013 T ES198787460013 T ES 198787460013T ES 87460013 T ES87460013 T ES 87460013T ES 2038689 T3 ES2038689 T3 ES 2038689T3
Authority
ES
Spain
Prior art keywords
viruses
infectious
rhythnotracheitis
pava
cultivation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787460013T
Other languages
English (en)
Inventor
Patrick Giraud
Georges Bennejean
Michele Guittet
Didier Toquin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MINISTERE DE L'AGRICULTURE DIRECTION DE QUALITE SERV VETERINAIRES LAB NATIONAL PATHOLOGIE AVIAIRE
Boehringer Ingelheim Animal Health France SAS
Original Assignee
MINISTERE DE L'AGRICULTURE DIRECTION DE QUALITE SERV VETERINAIRES LAB NATIONAL PATHOLOGIE AVIAIRE
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MINISTERE DE L'AGRICULTURE DIRECTION DE QUALITE SERV VETERINAIRES LAB NATIONAL PATHOLOGIE AVIAIRE, Rhone Merieux SA filed Critical MINISTERE DE L'AGRICULTURE DIRECTION DE QUALITE SERV VETERINAIRES LAB NATIONAL PATHOLOGIE AVIAIRE
Application granted granted Critical
Publication of ES2038689T3 publication Critical patent/ES2038689T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18361—Methods of inactivation or attenuation
    • C12N2760/18364—Methods of inactivation or attenuation by serial passage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL INVENTO CONSISTE EN UN PROCEDIMIENTO DE CULTIVO DE VIRUS DE LA RINOTRAQUEITIS INFECCIOSA DEL PAVO QUE ES RESPONSABLE IGUALMENTE DE AFECCIONES DE OTRAS ESPECIES AVICOLAS TALES COMO EL SINDROME INFECCIOSO DE GORDAS CABEZAS ( O DE INFLAMACION DE LA CABEZA DE LA GALLINA Y DE LA PINTADA). SEGUN EL INVENTO, SE EXTRAE DE MUESTRAS DE ANIMALES ENFERMOS, QUE SE INOCULAN SOBRE CULTIVOS CELULARES CONSTITUIDOS POR UNA ALINEACCION CONTINUA DE CELULAS DE RIÑON DE SIMIO. SE OBTIENE ASI UNA GRAN CANTIDAD DE VIRUS UTILIZABLE COMO ANTIGENO EN LA FABRICACCION DE UNA VACUNA PUDIENDO SER INDISTINTAMENTE UTILIZADA PARA LA IMUNIZACION DE TODAS LAS ESPECIES AVICOLAS. EL INVENTO SE APLICA IGUALMENTE A LA FABRICACION DE VACUNAS A PARTIR DE CEPAS VIRALES OBTENIDAS PARA ESTE PROCEDIMIENTO.
ES198787460013T 1986-08-18 1987-07-16 Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido. Expired - Lifetime ES2038689T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611872A FR2602791B1 (fr) 1986-08-18 1986-08-18 Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu

Publications (1)

Publication Number Publication Date
ES2038689T3 true ES2038689T3 (es) 1993-08-01

Family

ID=9338390

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787460013T Expired - Lifetime ES2038689T3 (es) 1986-08-18 1987-07-16 Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido.

Country Status (7)

Country Link
US (1) US4810493A (es)
EP (1) EP0263048B1 (es)
AT (1) ATE70561T1 (es)
CA (1) CA1277270C (es)
DE (1) DE3775321D1 (es)
ES (1) ES2038689T3 (es)
FR (1) FR2602791B1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
US5846805A (en) * 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US6080570A (en) * 1991-08-26 2000-06-27 Boehringer Ingelheim Vetmedica, Inc. Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
US6982160B2 (en) 1991-08-26 2006-01-03 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions that include SIRS virus
CA2076744C (en) * 1991-08-26 2000-06-27 Danny W. Chladek Viral agent associated with mystery swine disease
US20040224327A1 (en) * 1996-10-30 2004-11-11 Meulenberg Johanna Jacoba Maria Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (en) * 1996-10-30 1998-05-06 Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
WO2000053787A1 (en) 1999-03-08 2000-09-14 Id-Lelystad, Instituut Voor Dierhouderij En Dierg Ezondheid B.V. Prrsv vaccines
DK1183332T3 (da) 1999-04-22 2010-09-06 Us Agriculture Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
FR2801607B1 (fr) * 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
BRPI0510928A (pt) 2004-06-18 2007-11-13 Univ Minnesota identificação de organismos viralmente infectados e vacinados
US7632636B2 (en) 2004-09-21 2009-12-15 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome isolates and methods of use
UA95778C2 (ru) 2005-06-24 2011-09-12 Риджентс Оф Зе Юниверсити Оф Миннесота Вирусы репродуктивно-респираторного синдрома свиней, их инфекционные клоны и мутанты и способы применения
UA106475C2 (uk) * 2008-08-25 2014-09-10 Берингер Ингельхайм Ветмедика, Инк. Спосіб вакцинації свині проти високопатогенного репродуктивно-респіраторного синдрому свиней (hp prrs)
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
MY186535A (en) 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
WO2012110490A1 (en) 2011-02-17 2012-08-23 Boehringer Ingelheim Vetmedica Gmbh Commercial scale process for production of prrsv
US9187731B2 (en) 2011-07-29 2015-11-17 Boehringer Ingelheim Vetmedica Gmbh PRRS virus inducing type I interferon in susceptible cells
US9315781B2 (en) 2011-07-29 2016-04-19 Boehringer Ingelheim Vetmedica Gmbh Infectious CDNA clone of european PRRS virus and uses thereof
EP2968513A2 (en) 2013-03-15 2016-01-20 Boehringer Ingelheim Vetmedica, Inc. Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215107A (en) * 1978-12-29 1980-07-29 Merck & Co., Inc. Parainfluenza virus vaccine and its preparation
PT72077B (en) * 1979-11-30 1981-09-29 Gist Brocades Nv Infectious bronchitis vaccines for poultry and process forthe preparation of such vaccines
EP0073856A1 (en) * 1981-08-28 1983-03-16 Gist-Brocades N.V. Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines, process for preventing infectious bronchitis and infectious-bronchitis virus strain

Also Published As

Publication number Publication date
CA1277270C (fr) 1990-12-04
FR2602791B1 (fr) 1988-11-10
EP0263048A1 (fr) 1988-04-06
FR2602791A1 (fr) 1988-02-19
ATE70561T1 (de) 1992-01-15
EP0263048B1 (fr) 1991-12-18
US4810493A (en) 1989-03-07
DE3775321D1 (de) 1992-01-30

Similar Documents

Publication Publication Date Title
ES2038689T3 (es) Procedimiento de cultivo del virus de la rinotraqueitis infecciosa de la pava, y vacuna preparada a partir del virus asi obtenido.
KR0156732B1 (ko) 연속 셀 라인에서의 ibdv 생성
NZ521270A (en) Altered strain of the Modified Vaccinia virus Ankara (MVA) for growth in a continuous vero cell line
DK1183332T3 (da) Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
Pay et al. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process
EP0101348A3 (en) Avian proventriculitis vaccine, avian proventriculitis reovirus, process for preparing said vaccine and method of protecting a poultry animal against proventriculitis
ATE101200T1 (de) Impfstoffe gegen menschliche respiratorische viren.
ES553758A0 (es) Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
EP0125245B1 (en) Propagation of hemorrhagic enteritis virus in a turkey cell line
JPS55147227A (en) Preparrtion of attenuated live mumps vaccine
DE2962920D1 (en) Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
KR880001808A (ko) 닭의 전염병(전염성 후두기관염 및 마렉크병) 생 왁진
DE3064590D1 (en) Process for the preparation of influenza a virus vaccinating strains, vaccinating strain and vaccine containing it
JPH0571226B2 (es)
Berry et al. Inactivated bluetongue virus vaccine in lambs: differential serological responses related to breed
GR3006970T3 (es)
Igarashi A mutant of Chikungunya virus isolated from a line of Singh's Aedes albopictus cells by plaque formation on virus-sensitive cloned cells obtained from another Singh's A. albopictus cell line
Willems et al. Growth of Sendai virus in organ cultures of mouse tissue
GB1481650A (en) Chemical processes and products
BG61384B1 (bg) метод за получаване на жива атенуирана клетъчно-културална ваксина против псевдочума по птиците
Fabry et al. High density microcarrier cell culture for viral vaccine production.
SE8700466L (sv) Vacciner mor melanom
Nishibe et al. Induction of SMON-type virus from avian infectious laryngotracheitis virus
RU2020136260A (ru) Живой аттенуированный штамм вируса желтой лихорадки, адаптированный к росту в клетках vero, и вакцинная композиция, содержащая его

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 263048

Country of ref document: ES